Fatty acid composition in chronic heart failure: Low circulating levels of eicosatetraenoic acid and high levels of vaccenic acid are associated with disease severity and mortality

Journal of Internal Medicine

Volumn 270, Issue 3, 2011, Pages 263-272

  Oie, E ^a,b   Ueland, T ^a,c   Dahl, C P ^a,b   Bohov, P ^d   Berge, C ^d,e   Yndestad, A ^a,b,c   Gullestad, L ^a,b,c   Aukrust, P ^a,c   Berge, R K ^d  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

Congestive heart failure; Fatty acids; Lipids

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; DIGITOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH SENSITIVITY C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; ICOSATETRAENOIC ACID; LONG CHAIN FATTY ACID; OMEGA 3 FATTY ACID; UNCLASSIFIED DRUG; VACCENIC ACID; WARFARIN;

ADULT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART FAILURE; HEART FUNCTION; HUMAN; LIPID BLOOD LEVEL; LIPID COMPOSITION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ARACHIDONIC ACIDS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC DISEASE; CONFOUNDING FACTORS (EPIDEMIOLOGY); DISEASE PROGRESSION; FATTY ACIDS, UNSATURATED; FEMALE; HEART FAILURE; HUMANS; INFLAMMATION; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; OLEIC ACIDS; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; SEVERITY OF ILLNESS INDEX;

EID: 80051570474     PISSN: 09546820     EISSN: 13652796     Source Type: Journal    
DOI: 10.1111/j.1365-2796.2011.02384.x     Document Type: Article

References (28)

1. Ventura-Clapier R, Garnier A, Veksler V. Energy metabolism in heart failure. J Physiol 2004; 555: 1-13.
2. Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiol Rev 2005; 85: 1093-129.
3. Opie LH, Knuuti J. The adrenergic-fatty acid load in heart failure. J Am Coll Cardiol 2009; 54: 1637-46.
4. Neubauer S. The failing heart-an engine out of fuel. N Engl J Med 2007; 356: 1140-51.
5. Nasa Y, Sakamoto Y, Sanbe A, Sasaki H, Yamaguchi F, Takeo S. Changes in fatty acid compositions of myocardial lipids in rats with heart failure following myocardial infarction. Mol Cell Biochem 1997; 176: 179-89.
6. Yamagishi K, Nettleton JA, Folsom AR. Plasma fatty acid composition and incident heart failure in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2008; 156: 965-74.
7. Yamagishi K, Iso H, Date C et al., Japan Collaborative Cohort Study for Evaluation of Cancer Risk Study Group. Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study. J Am Coll Cardiol 2008; 52: 988-96.
8. Gissi-HF Investigators, Tavazzi L, Maggioni AP, Marchioli R et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008; 372: 1223-30.
9. Wergedahl H, Liaset B, Gudbrandsen OA et al. Fish protein hydrolysate reduces plasma total cholesterol, increases the proportion of HDL cholesterol, and lowers acyl-CoA:cholesterol acyltransferase activity in liver of Zucker rats. J Nutr 2004; 134: 1320-7.
10. Mozaffarian D, Bryson CL, Lemaitre RN, Burke GL, Siscovick DS. Fish intake and risk of incident heart failure. J Am Coll Cardiol 2005; 45: 2015-21.
11. Duda MK, O'Shea KM, Stanley WC. Ω-3 polyunsaturated fatty acid supplementation for the treatment of heart failure: mechanisms and clinical potential. Cardiovasc Res 2009; 84: 33-41.
12. Dyerberg J, Bang HO, Stoffersen E, Moncada S, Vane JR. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 1978; 2: 117-9.
13. Calder PC. n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006; 83(Suppl): 1505S-19S.
14. Raitt MH, Connor WE, Morris C et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA 2005; 293: 2884-91.
15. Chin JP, Gust AP, Nestel PJ, Dart AM. Marine oils dose-dependently inhibit vasoconstriction of forearm resistance vessels in humans. Hypertension 1993; 21: 22-8.
16. Li Q, Zhang Q, Wang M et al. Docosahexaenoic acid affects endothelial nitric oxide synthase in caveolae. Arch Biochem Biophys 2007; 466: 250-9.
17. London B, Albert C, Anderson ME et al. Omega-3 fatty acids and cardiac arrhythmias: prior studies and recommendations for future research: a report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and their Role in Cardiac Arrhythmogenesis Workshop. Circulation 2007; 116: e320-35.
18. 2α) from 20:4n-6 (arachidonic acid). Fish Physiol Biochem 2002; 27: 81-96.
19. Smith RD, Kelly CN, Fielding BA et al. Long-term monounsaturated fatty acid diets reduce platelet aggregation in healthy young subjects. Br J Nutr 2003; 90: 597-606.
20. Appel LJ, Sacks FM, Carey VJ et al., OmniHeart Collaborative Research Group. Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: results of the OmniHeart randomized trial. JAMA 2005; 294: 2455-64.
21. Cao H, Gerhold K, Mayers JR, Wiest MM, Watkins SM, Hotamisligil GS. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 2008; 134: 933-44.
22. Takahashi R, Okumura K, Asai T et al. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res 2005; 68: 213-23.
23. Lemaitre RN, King IB, Sotoodehnia N et al. Endogenous red blood cell membrane fatty acids and sudden cardiac arrest. Metabolism 2010; 59: 1029-34.
24. Li ZZ, Berk M, McIntyre TM, Feldstein AE. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase. J Biol Chem 2009; 284: 5637-44.
25. Halvorsen B, Rustan AC, Madsen L et al. Effects of long-chain monounsaturated and n-3 fatty acids on fatty acid oxidation and lipid composition in rats. Ann Nutr Metab 2001; 45: 30-7.
26. Morel S, Berthonneche C, Tanguy S et al. Insulin resistance modifies plasma fatty acid distribution and decreases cardiac tolerance to in vivo ischaemia/reperfusion in rats. Clin Exp Pharmacol Physiol 2003; 30: 446-51.
27. Mjøs OD. Effect of free fatty acids on myocardial function and oxygen consumption in intact dogs. J Clin Invest 1971; 50: 1386-9.
28. Murray AJ, Cole MA, Lygate CA et al. Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. J Mol Cell Cardiol 2008; 44: 694-700.